GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.99
-0.62 (-1.20%)
May 4, 2026, 10:26 AM EDT - Market open
GSK Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6,356 | 6,289 | 2,951 | 5,308 | 4,921 | 3,516 |
Depreciation & Amortization | - | 2,314 | 2,551 | 2,294 | 2,147 | 2,122 |
Stock-Based Compensation | - | 374 | 344 | 307 | 346 | 343 |
Other Adjustments | 3,640 | 4,522 | 6,669 | 3,831 | 4,911 | 4,677 |
Change in Receivables | - | -1,097 | 340 | -649 | -616 | -1,162 |
Changes in Inventories | - | -140 | -294 | -424 | -269 | 51 |
Changes in Accounts Payable | - | 131 | -179 | -15 | 494 | 229 |
Changes in Income Taxes Payable | -1,255 | -1,202 | -1,307 | -1,328 | -1,473 | -1,291 |
Changes in Other Operating Activities | -2,966 | -796 | 389 | 232 | -35 | 3,200 |
Operating Cash Flow | 7,737 | 7,741 | 6,554 | 6,768 | 7,403 | 7,952 |
Operating Cash Flow Growth | 14.77% | 18.11% | -3.16% | -8.58% | -6.90% | -5.79% |
Capital Expenditures | -1,361 | -1,348 | -1,399 | -1,314 | -1,143 | -950 |
Sale of Property, Plant & Equipment | 50 | 24 | 65 | 28 | 146 | 132 |
Purchases of Intangible Assets | -1,619 | -1,637 | -1,583 | -1,030 | -1,115 | -1,704 |
Proceeds from Sale of Intangible Assets | 101 | 115 | 131 | 12 | 196 | 641 |
Purchases of Investments | -76 | -92 | -146 | -123 | -144 | -163 |
Proceeds from Sale of Investments | 192 | 189 | 2,356 | 1,833 | 238 | 479 |
Payments for Business Acquisitions | -2,314 | -1,709 | -824 | -1,468 | -3,187 | -114 |
Proceeds from Business Divestments | 219 | -27 | -18 | 49 | -43 | -17 |
Other Investing Activities | 253 | 252 | 189 | 418 | -3,720 | -81 |
Investing Cash Flow | -4,555 | -4,233 | -1,229 | -1,595 | -8,772 | -1,777 |
Short-Term Debt Issued | 2,358 | 1,215 | -545 | -333 | 1,021 | 301 |
Short-Term Debt Repaid | -149 | -288 | -81 | - | - | -2,304 |
Net Short-Term Debt Issued (Repaid) | 2,209 | 927 | -626 | -333 | 1,021 | -2,003 |
Long-Term Debt Issued | -39 | 1,979 | 1,075 | 223 | 1,025 | - |
Long-Term Debt Repaid | -695.5 | -1,400 | -1,615 | -2,260 | -6,668 | - |
Net Long-Term Debt Issued (Repaid) | -734.5 | 579 | -540 | -2,037 | -5,643 | - |
Issuance of Common Stock | 11 | 15 | 20 | 10 | 25 | 21 |
Repurchase of Common Stock | -1,456 | -1,377 | - | - | - | - |
Net Common Stock Issued (Repurchased) | -1,445 | -1,362 | 20 | 10 | 25 | 21 |
Common Dividends Paid | -2,595 | -2,564 | -2,444 | -2,247 | -3,467 | -3,999 |
Other Financing Activities | -1,001 | -1,265 | -1,136 | -1,034 | 8,887 | -1,608 |
Financing Cash Flow | -4,271 | -3,685 | -4,726 | -5,641 | 823 | -7,589 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -6 | -19 | -54 | -99 | 152 | -29 |
Net Cash Flow | -1,089 | -177 | 599 | -468 | -546 | -1,414 |
Free Cash Flow | 6,376 | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 |
Free Cash Flow Growth | -0.27% | 24.02% | -5.48% | -12.88% | -10.60% | -6.04% |
FCF Margin | 19.45% | 19.57% | 16.43% | 17.98% | 21.35% | 28.35% |
Free Cash Flow Per Share | 3.12 | 3.11 | 2.49 | 2.65 | 3.07 | 3.46 |
Levered Free Cash Flow | 1,722 | 6,181 | 1,170 | 2,003 | 10,055 | 5,743 |
Unlevered Free Cash Flow | 1,263 | 5,699 | 3,174 | 5,349 | 5,346 | 7,618 |
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.